News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Treatment guidelines news

Show

From To
Treatment guidelines
South Africa: ARVS open to all: Motlanthe

All HIV patients with a CD4 count of 350 or less will now get government antiretroviral (ARV) treatment, Deputy President Kgalema Motlanthe announced.

Published
12 August 2011
From
Times Live
Treatment-experienced people
Low stock: HIV patients denied second-line drugs

About 750 HIV patients requiring advanced treatment in the state are forced to go without life-saving second-line anti-retroviral therapy (ART) drugs which are in short supply.

Published
07 August 2011
From
Times of India
Undetectable viral load and treatment as prevention
Médecins Sans Frontières: Treatment As Prevention - We Urgently Need Policy Guidance

Rumours spread in the conference corridors that WHO had been pressured to delay the release of guidelines on the provision of ART in discordant couples. Some suggested the issue at stake was to find the right balance in investment between the results of HTPN 052 and those of the recently completed pre-exposure prophylaxis trials.

Published
26 July 2011
From
Speaking of Medicine
Treatment guidelines
Treating HIV sooner would save South African lives and money

If South Africa followed a new World Health Organization recommendation to give antiretroviral therapy to people with HIV when they were still at a higher level of health, it would reduce new infections, lengthen thousands of lives, and recoup the government's investment by 2026, according to new research.

Published
25 July 2011
From
Science Daily
Treatment guidelines
Abacavir matches tenofovir in Canadian patients with high viral load

The abacavir/3TC nucleoside combination is as potent as tenofovir/FTC, Canadian investigators report in the online edition of the Journal of Acquired Immune Deficiency Syndromes.  The study involved patients

Published
13 July 2011
By
Michael Carter
Side-effects
Global safety monitoring of HIV drugs is essential, says International Forum

With increasing numbers of people worldwide -- five million in 2010 -- on antiretroviral drugs for the treatment of HIV, the International Forum for Collaborative HIV Research recommends that improved and sustained global drug safety monitoring, including monitoring for substandard products, drug diversion, inappropriate use and toxicity, is critical.

Published
05 July 2011
From
Eurekalert HIV
Hepatitis B
3TC has limited impact on HBV for hepatitis B / HIV-coinfected in South African trial

The inclusion of 3TC in antiretroviral therapy had few additional benefits for South African HIV-positive patients co-infected with hepatitis B, South African investigators report in the online edition

Published
05 July 2011
By
Keith Alcorn
Bone and joint problems
Panel Issues New Guidelines on Ideal Vitamin D Levels

An expert panel has issued new recommendations suggesting that people with HIV might require two to three times the level of vitamin D as their HIV-negative peers.

Published
10 June 2011
From
AIDSMeds.com
Treatment guidelines
MALAWI: Fears of Sustainability of New ART Regime

As government prepares to roll out the expensive new antiretroviral treatment regime recommended by the World Health Organisation (WHO) this month, there are fears about the programme's sustainability after two recent proposals for funding were rejected by the Global Fund.

Published
09 June 2011
From
Inter Press Service
Changing treatment
International team to investigate second-line HIV therapy in Africa

The largest clinical trial to investigate treatment options for individuals whose first combination of anti-HIV medicines is no longer working has been announced following the recruitment of 1,200 HIV-positive individuals from across five African

Published
18 May 2011
From
University College Dublin
← Prev1...3233343536...40Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.